Carcinoma, Pancreatic Ductal
-
Subject Areas on Research
-
A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas.
-
A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients.
-
A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer.
-
A niche role for cancer exosomes in metastasis.
-
A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.
-
ACR Appropriateness Criteria® Staging of Pancreatic Ductal Adenocarcinoma.
-
ASO Author Reflections: Progression after Resection of Noninvasive or Microinvasive Intraductal Papillary Mucinous Neoplasms.
-
Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study.
-
Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry.
-
Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer.
-
Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence?
-
CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma.
-
Cilia loss sensitizes cells to transformation by activating the mevalonate pathway.
-
Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
-
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers.
-
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment.
-
Current Controversy of Radiographic Surveillance of Patients With Branch-duct IPMN and Pancreatic Cysts: Commentary on: Ductal Carcinoma Arising in a Largely Unchanged Presumed Branch Duct IPMN After 10 Years of Surveillance.
-
Cyst Fluid Analysis in Pancreatic Intraductal Papillary Mucinous Neoplasms.
-
Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas.
-
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.
-
Deciphering the mechanisms of tumorigenesis in human pancreatic ductal epithelial cells.
-
Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance.
-
Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
-
Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells.
-
Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer.
-
Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer.
-
Diagnostic and therapeutic implications of a novel immunohistochemical panel detecting duodenal mucosal invasion by pancreatic ductal adenocarcinoma.
-
Differential Cell Susceptibilities to KrasG12D in the Setting of Obstructive Chronic Pancreatitis.
-
Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
-
Differing molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients.
-
Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cδ activation in pancreatic ductal adenocarcinoma.
-
Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms.
-
Early onset pancreatic malignancies: Clinical characteristics and survival associations.
-
Effects of base excision repair gene polymorphisms on pancreatic cancer survival.
-
Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis.
-
Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
-
Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer.
-
FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma.
-
Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression.
-
Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm.
-
Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction.
-
GFRα1 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling.
-
GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
-
GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs".
-
Glucose metabolism gene polymorphisms and clinical outcome in pancreatic cancer.
-
Hepatic arterial nodal metastases in pancreatic cancer: is this the node of importance?
-
High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinoma.
-
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome.
-
ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer.
-
Identification of novel predictive markers for the prognosis of pancreatic ductal adenocarcinoma.
-
Imaging comparison of tubular and colloid pancreatic adenocarcinoma arising from intraductal papillary mucinous neoplasm on multidetector CT.
-
In vivo and in vitro propagation of intraductal papillary mucinous neoplasms.
-
Incidentally discovered pancreatic intraepithelial neoplasia: what is its clinical significance?
-
Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.
-
Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer.
-
Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT.
-
Intraductal Oncocytic Papillary Neoplasms: Clinical-Pathologic Characterization of 24 Cases, With An Emphasis on Associated Invasive Carcinomas.
-
Intraductal Papillary Mucinous Neoplasm of the Pancreas in Young Patients: Tumor Biology, Clinical Features, and Survival Outcomes.
-
Intraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection Versus Observation.
-
Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases.
-
Intraductal papillary mucinous neoplasm.
-
Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.
-
Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?
-
Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma.
-
Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
-
KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.
-
Liberal resection for (presumed) Sendai negative branch-duct intraductal papillary mucinous neoplasms--also not harmless.
-
Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer.
-
Loss of HNF6 expression correlates with human pancreatic cancer progression.
-
Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma.
-
Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation.
-
Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma.
-
Measurement of Reactive Oxygen Species by Fluorescent Probes in Pancreatic Cancer Cells.
-
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.
-
MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1.
-
Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.
-
Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative exploration.
-
NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma.
-
Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting.
-
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
-
Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2.
-
Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma.
-
Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma.
-
PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice.
-
PORCN inhibition synergizes with PI3K/mTOR inhibition in Wnt-addicted cancers.
-
Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.
-
Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm.
-
Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm.
-
Pancreatic ductal adenocarcinoma with autoimmune pancreatitis-like histologic and immunohistochemical features.
-
Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.
-
Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma.
-
Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis.
-
Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma.
-
Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.
-
Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation.
-
Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.
-
Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
-
Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram.
-
Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients.
-
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.
-
Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases.
-
Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
-
Quantitative and Qualitative Comparison of Single-Source Dual-Energy Computed Tomography and 120-kVp Computed Tomography for the Assessment of Pancreatic Ductal Adenocarcinoma.
-
Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice.
-
Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation.
-
Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype.
-
Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis.
-
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
-
Roux-en-Y reconstruction after pancreaticoduodenectomy.
-
SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms.
-
Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.
-
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.
-
Serum biomarker panels for the detection of pancreatic cancer.
-
Should all branch-duct intraductal papillary mucinous neoplasms be resected?
-
Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
-
Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival.
-
Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity.
-
Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer.
-
Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis.
-
Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades.
-
TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.
-
Targeting cell surface GRP78 enhances pancreatic cancer radiosensitivity through YAP/TAZ protein signaling.
-
Targeting eNOS in pancreatic cancer.
-
The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
-
The Oncogenesis in Patients With Pancreatic Intraductal Papillary Mucinous Neoplasms: Taking the Thread From the Beginning.
-
The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk.
-
The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma.
-
The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting.
-
The efficacy and safety of the open approach irreversible electroporation in the treatment of pancreatic cancer: A systematic review.
-
The management of intraductal papillary mucinous neoplasms of the pancreas.
-
The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression.
-
The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study.
-
The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis.
-
The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia.
-
The subcellular localization of syntaxin 17 varies among different cell types and is altered in some malignant cells.
-
Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.
-
Transport properties of pancreatic cancer describe gemcitabine delivery and response.
-
Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy.
-
Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease.
-
Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: a radiographic finding with potentially increased malignant potential.
-
Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
-
Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer.
-
p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis.
-
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation.